TY - JOUR AU - Lemmon, M. A. AU - Schlessinger, J. PY - 2010 DA - 2010// TI - Cell signaling by receptor tyrosine kinases JO - Cell VL - 141 UR - https://doi.org/10.1016/j.cell.2010.06.011 DO - 10.1016/j.cell.2010.06.011 ID - Lemmon2010 ER - TY - JOUR AU - Blume-Jensen, P. e. t. e. r. AU - Hunter, T. o. n. y. PY - 2001 DA - 2001// TI - Oncogenic kinase signalling JO - Nature VL - 411 UR - https://doi.org/10.1038/35077225 DO - 10.1038/35077225 ID - Blume-Jensen2001 ER - TY - JOUR AU - Ullrich, A. AU - Schlessinger, J. PY - 1990 DA - 1990// TI - Signal transduction by receptors with tyrosine kinase activity JO - Cell VL - 61 UR - https://doi.org/10.1016/0092-8674(90)90801-K DO - 10.1016/0092-8674(90)90801-K ID - Ullrich1990 ER - TY - JOUR AU - Burgess, A. W. PY - 2003 DA - 2003// TI - An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors JO - Mol Cell VL - 12 UR - https://doi.org/10.1016/S1097-2765(03)00350-2 DO - 10.1016/S1097-2765(03)00350-2 ID - Burgess2003 ER - TY - JOUR AU - Sharma, S. V. AU - Bell, D. W. AU - Settleman, J. AU - Haber, D. A. PY - 2007 DA - 2007// TI - Epidermal growth factor receptor mutations in lung cancer JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2088 DO - 10.1038/nrc2088 ID - Sharma2007 ER - TY - JOUR AU - Zhang, X. AU - Gureasko, J. AU - Shen, K. AU - Cole, P. A. AU - Kuriyan, J. PY - 2006 DA - 2006// TI - An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor JO - Cell VL - 125 UR - https://doi.org/10.1016/j.cell.2006.05.013 DO - 10.1016/j.cell.2006.05.013 ID - Zhang2006 ER - TY - JOUR AU - Corless, C. L. AU - Heinrich, M. C. PY - 2008 DA - 2008// TI - Molecular pathobiology of gastrointestinal stromal sarcomas JO - Annu Rev Pathol VL - 3 UR - https://doi.org/10.1146/annurev.pathmechdis.3.121806.151538 DO - 10.1146/annurev.pathmechdis.3.121806.151538 ID - Corless2008 ER - TY - JOUR AU - Forbes, S. A. PY - 2010 DA - 2010// TI - COSMIC (the catalogue of somatic mutations in Cancer): a resource to investigate acquired mutations in human cancer JO - Nucleic Acids Res VL - 38 UR - https://doi.org/10.1093/nar/gkp995 DO - 10.1093/nar/gkp995 ID - Forbes2010 ER - TY - JOUR AU - Stagno, F. PY - 2016 DA - 2016// TI - Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes JO - Expert Rev Anticancer Ther VL - 16 UR - https://doi.org/10.1586/14737140.2016.1151356 DO - 10.1586/14737140.2016.1151356 ID - Stagno2016 ER - TY - JOUR AU - Trent, J. C. AU - Subramanian, M. P. PY - 2014 DA - 2014// TI - Managing GIST in the imatinib era: optimization of adjuvant therapy JO - Expert Rev Anticancer Ther VL - 14 UR - https://doi.org/10.1586/14737140.2014.952284 DO - 10.1586/14737140.2014.952284 ID - Trent2014 ER - TY - JOUR AU - Chen, Y. AU - Fu, L. PY - 2011 DA - 2011// TI - Mechanisms of acquired resistance to tyrosine kinase inhibitors JO - Acta Pharm Sin B VL - 1 UR - https://doi.org/10.1016/j.apsb.2011.10.007 DO - 10.1016/j.apsb.2011.10.007 ID - Chen2011 ER - TY - JOUR AU - Alexander, P. B. AU - Wang, X. -. F. PY - 2015 DA - 2015// TI - Resistance to receptor tyrosine kinase inhibition in cancer: molecular mechanisms and therapeutic strategies JO - Front Med VL - 9 UR - https://doi.org/10.1007/s11684-015-0396-9 DO - 10.1007/s11684-015-0396-9 ID - Alexander2015 ER - TY - JOUR AU - Corcoran, C. AU - O’Driscoll, L. PY - 2015 DA - 2015// TI - Receptor tyrosine kinases and drug resistance: development and characterization of in vitro models of resistance to RTK inhibitors JO - Methods Mol Biol VL - 1233 UR - https://doi.org/10.1007/978-1-4939-1789-1_16 DO - 10.1007/978-1-4939-1789-1_16 ID - Corcoran2015 ER - TY - JOUR AU - Aveic, S. AU - Tonini, G. P. PY - 2016 DA - 2016// TI - Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy? JO - Cancer Cell Int VL - 16 UR - https://doi.org/10.1186/s12935-016-0341-2 DO - 10.1186/s12935-016-0341-2 ID - Aveic2016 ER - TY - JOUR AU - Raman, M. AU - Chen, W. AU - Cobb, M. H. PY - 2007 DA - 2007// TI - Differential regulation and properties of MAPKs JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210392 DO - 10.1038/sj.onc.1210392 ID - Raman2007 ER - TY - JOUR AU - Bromann, P. A. AU - Korkaya, H. AU - Courtneidge, S. A. PY - 2004 DA - 2004// TI - The interplay between Src family kinases and receptor tyrosine kinases JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208079 DO - 10.1038/sj.onc.1208079 ID - Bromann2004 ER - TY - JOUR AU - Trusolino, L. AU - Bertotti, A. AU - Comoglio, P. M. PY - 2010 DA - 2010// TI - MET signalling: principles and functions in development, organ regeneration and cancer JO - Nat Rev Mol Cell Biol VL - 11 UR - https://doi.org/10.1038/nrm3012 DO - 10.1038/nrm3012 ID - Trusolino2010 ER - TY - JOUR AU - Santos, S. D. M. AU - Verveer, P. J. AU - Bastiaens, P. I. H. PY - 2007 DA - 2007// TI - Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate JO - Nat Cell Biol VL - 9 UR - https://doi.org/10.1038/ncb1543 DO - 10.1038/ncb1543 ID - Santos2007 ER - TY - JOUR AU - Marmor, M. D. AU - Yarden, Y. PY - 2004 DA - 2004// TI - Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207390 DO - 10.1038/sj.onc.1207390 ID - Marmor2004 ER - TY - JOUR AU - Jiang, Y. PY - 2002 DA - 2002// TI - Crystal structure and mechanism of a calcium-gated potassium channel JO - Nature VL - 417 UR - https://doi.org/10.1038/417515a DO - 10.1038/417515a ID - Jiang2002 ER - TY - JOUR AU - Kanehisa, M. AU - Sato, Y. AU - Kawashima, M. AU - Furumichi, M. AU - Tanabe, M. PY - 2016 DA - 2016// TI - KEGG as a reference resource for gene and protein annotation JO - Nucleic Acids Res VL - 44 UR - https://doi.org/10.1093/nar/gkv1070 DO - 10.1093/nar/gkv1070 ID - Kanehisa2016 ER - TY - JOUR AU - Zhang, M. PY - 2018 DA - 2018// TI - Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction JO - Oncotarget VL - 9 ID - Zhang2018 ER - TY - JOUR AU - Barretina, J. PY - 2012 DA - 2012// TI - The Cancer cell line encyclopedia enables predictive modeling of anticancer drug sensitivity JO - Nature VL - 483 UR - https://doi.org/10.1038/nature11003 DO - 10.1038/nature11003 ID - Barretina2012 ER - TY - CHAP AU - Saad, C. AU - Bauer, B. PY - 2013 DA - 2013// TI - Data-flow based model analysis and its applications BT - Model-driven engineering languages and systems PB - Springer CY - Berlin UR - https://doi.org/10.1007/978-3-642-41533-3_43 DO - 10.1007/978-3-642-41533-3_43 ID - Saad2013 ER - TY - JOUR AU - Zou, H. Y. PY - 2007 DA - 2007// TI - An orally available small-molecule inhibitor of c-met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-4443 DO - 10.1158/0008-5472.CAN-06-4443 ID - Zou2007 ER - TY - JOUR AU - Monaco, M. E. PY - 2017 DA - 2017// TI - Fatty acid metabolism in breast cancer subtypes JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.15494 DO - 10.18632/oncotarget.15494 ID - Monaco2017 ER - TY - JOUR AU - Lien, E. v. a. n. C. AU - Ghisolfi, L. a. u. r. a. AU - Geck, R. e. n. e. e. C. AU - Asara, J. o. h. n. M. AU - Toker, A. l. e. x. PY - 2017 DA - 2017// TI - Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT JO - Science Signaling VL - 10 UR - https://doi.org/10.1126/scisignal.aao6604 DO - 10.1126/scisignal.aao6604 ID - Lien2017 ER - TY - JOUR AU - Jiang, Y. PY - 2016 DA - 2016// TI - A sucrose-enriched diet promotes tumorigenesis in mammary gland in part through the 12-lipoxygenase pathway JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-14-3432 DO - 10.1158/0008-5472.CAN-14-3432 ID - Jiang2016 ER - TY - JOUR AU - Jiang, Y. PY - 2017 DA - 2017// TI - Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis JO - Theranostics VL - 7 UR - https://doi.org/10.7150/thno.18005 DO - 10.7150/thno.18005 ID - Jiang2017 ER - TY - JOUR AU - Lake, A. D. PY - 2011 DA - 2011// TI - Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease JO - Drug Metab Dispos VL - 39 UR - https://doi.org/10.1124/dmd.111.040592 DO - 10.1124/dmd.111.040592 ID - Lake2011 ER - TY - JOUR AU - Chini, C. C. S. PY - 2014 DA - 2014// TI - Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors JO - Clin Cancer Res Off J Am Assoc Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-0150 DO - 10.1158/1078-0432.CCR-13-0150 ID - Chini2014 ER - TY - JOUR AU - Cantó, C. AU - Menzies, K. AU - Auwerx, J. PY - 2015 DA - 2015// TI - NAD+ metabolism and the control of energy homeostasis - a balancing act between mitochondria and the nucleus JO - Cell Metab VL - 22 UR - https://doi.org/10.1016/j.cmet.2015.05.023 DO - 10.1016/j.cmet.2015.05.023 ID - Cantó2015 ER - TY - JOUR AU - Liu, H. AU - Dong, H. AU - Robertson, K. AU - Liu, C. PY - 2011 DA - 2011// TI - DNA methylation suppresses expression of the urea cycle enzyme carbamoyl phosphate Synthetase 1 (CPS1) in human hepatocellular carcinoma JO - Am J Pathol VL - 178 UR - https://doi.org/10.1016/j.ajpath.2010.10.023 DO - 10.1016/j.ajpath.2010.10.023 ID - Liu2011 ER - TY - JOUR AU - Canter, J. A. PY - 2007 DA - 2007// TI - Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study JO - Mitochondrion VL - 7 UR - https://doi.org/10.1016/j.mito.2006.11.001 DO - 10.1016/j.mito.2006.11.001 ID - Canter2007 ER - TY - JOUR AU - Barr, F. E. PY - 2007 DA - 2007// TI - Pharmacokinetics and safety of intravenously administered citrulline in children undergoing congenital heart surgery: potential therapy for postoperative pulmonary hypertension JO - J Thorac Cardiovasc Surg VL - 134 UR - https://doi.org/10.1016/j.jtcvs.2007.02.043 DO - 10.1016/j.jtcvs.2007.02.043 ID - Barr2007 ER - TY - JOUR AU - Iyama, T. AU - Abolhassani, N. AU - Tsuchimoto, D. AU - Nonaka, M. AU - Nakabeppu, Y. PY - 2010 DA - 2010// TI - NUDT16 is a (deoxy)inosine diphosphatase, and its deficiency induces accumulation of single-strand breaks in nuclear DNA and growth arrest JO - Nucleic Acids Res VL - 38 UR - https://doi.org/10.1093/nar/gkq249 DO - 10.1093/nar/gkq249 ID - Iyama2010 ER - TY - JOUR AU - Prados, M. D. PY - 2009 DA - 2009// TI - Phase II study of Erlotinib plus Temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma Multiforme or Gliosarcoma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.9639 DO - 10.1200/JCO.2008.18.9639 ID - Prados2009 ER - TY - JOUR AU - Thiessen, B. PY - 2010 DA - 2010// TI - A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation JO - Cancer Chemother Pharmacol VL - 65 UR - https://doi.org/10.1007/s00280-009-1041-6 DO - 10.1007/s00280-009-1041-6 ID - Thiessen2010 ER - TY - JOUR AU - Hainsworth John, D. PY - 2010 DA - 2010// TI - Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25275 DO - 10.1002/cncr.25275 ID - Hainsworth John2010 ER - TY - JOUR AU - Park, I. PY - 2014 DA - 2014// TI - Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of Temozolomide response in glioblastoma cells JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0849 DO - 10.1158/0008-5472.CAN-14-0849 ID - Park2014 ER - TY - JOUR AU - Oppermann, H. PY - 2016 DA - 2016// TI - Metabolic response of glioblastoma cells associated with glucose withdrawal and pyruvate substitution as revealed by GC-MS JO - Nutr Metab VL - 13 UR - https://doi.org/10.1186/s12986-016-0131-9 DO - 10.1186/s12986-016-0131-9 ID - Oppermann2016 ER - TY - JOUR AU - Haliloglu, G. PY - 2008 DA - 2008// TI - L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings JO - Neuropediatrics VL - 39 UR - https://doi.org/10.1055/s-2008-1081217 DO - 10.1055/s-2008-1081217 ID - Haliloglu2008 ER - TY - JOUR AU - Vilarinho, L. PY - 2010 DA - 2010// TI - Identification of novel L2HGDH gene mutations and update of the pathological spectrum JO - J Hum Genet VL - 55 UR - https://doi.org/10.1038/jhg.2009.110 DO - 10.1038/jhg.2009.110 ID - Vilarinho2010 ER - TY - JOUR AU - Shim, E. -. H. PY - 2014 DA - 2014// TI - L-2-Hydroxyglutarate: an epigenetic modifier and putative Oncometabolite in renal Cancer JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0696 DO - 10.1158/2159-8290.CD-13-0696 ID - Shim2014 ER - TY - JOUR AU - Ryu, J. K. AU - McLarnon, J. G. PY - 2016 DA - 2016// TI - Pyruvate blocks blood-brain barrier disruption, lymphocyte infiltration and immune response in excitotoxic brain injury JO - Am J Neurodegener Dis VL - 5 ID - Ryu2016 ER - TY - STD TI - Ma S, et al. L2hgdh deficiency accumulates l-2-Hydroxyglutarate with progressive leukoencephalopathy and neurodegeneration. Mol Cell Biol. 2017;37:8. ID - ref46 ER - TY - JOUR AU - Peyre, M. PY - 2010 DA - 2010// TI - Portrait of Ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0012932 DO - 10.1371/journal.pone.0012932 ID - Peyre2010 ER - TY - JOUR AU - Jinnah, H. A. AU - Sabina, R. L. AU - Berghe, G. PY - 2013 DA - 2013// TI - Metabolic disorders of purine metabolism affecting the nervous system JO - Handb Clin Neurol VL - 113 UR - https://doi.org/10.1016/B978-0-444-59565-2.00052-6 DO - 10.1016/B978-0-444-59565-2.00052-6 ID - Jinnah2013 ER - TY - JOUR AU - Hirano, M. AU - Peters, G. J. PY - 2016 DA - 2016// TI - Advances in purine and pyrimidine metabolism in health and diseases JO - Nucleosides Nucleotides Nucleic Acids VL - 35 UR - https://doi.org/10.1080/15257770.2016.1218022 DO - 10.1080/15257770.2016.1218022 ID - Hirano2016 ER - TY - JOUR AU - Widakowich, C. AU - Castro, G. AU - Azambuja, E. AU - Dinh, P. AU - Awada, A. PY - 2007 DA - 2007// TI - Review: side effects of approved molecular targeted therapies in solid cancers JO - Oncologist VL - 12 UR - https://doi.org/10.1634/theoncologist.12-12-1443 DO - 10.1634/theoncologist.12-12-1443 ID - Widakowich2007 ER - TY - JOUR AU - Lodish, M. B. AU - Stratakis, C. A. PY - 2010 DA - 2010// TI - Endocrine side effects of broad-acting kinase inhibitors JO - Endocr Relat Cancer VL - 17 UR - https://doi.org/10.1677/ERC-10-0082 DO - 10.1677/ERC-10-0082 ID - Lodish2010 ER - TY - JOUR AU - Lodish, M. B. PY - 2013 DA - 2013// TI - Kinase inhibitors: adverse effects related to the endocrine system JO - J Clin Endocrinol Metab VL - 98 UR - https://doi.org/10.1210/jc.2012-4085 DO - 10.1210/jc.2012-4085 ID - Lodish2013 ER - TY - JOUR AU - Esparís-Ogando, A. PY - 2008 DA - 2008// TI - Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdn406 DO - 10.1093/annonc/mdn406 ID - Esparís-Ogando2008 ER - TY - JOUR AU - Hartog, H. AU - Graaf, W. T. A. AU - Boezen, H. M. AU - Wesseling, J. PY - 2012 DA - 2012// TI - Treatment of breast cancer cells by IGF1R tyrosine kinase inhibitor combined with conventional systemic drugs JO - Anticancer Res VL - 32 ID - Hartog2012 ER - TY - JOUR AU - Wu, W. PY - 2017 DA - 2017// TI - Co-targeting IGF-1R and autophagy enhances the effects of cell growth suppression and apoptosis induced by the IGF-1R inhibitor NVP-AEW541 in triple-negative breast Cancer cells JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0169229 DO - 10.1371/journal.pone.0169229 ID - Wu2017 ER - TY - JOUR AU - Zafrakas, M. AU - Papasozomenou, P. AU - Emmanouilides, C. PY - 2016 DA - 2016// TI - Sorafenib in breast cancer treatment: a systematic review and overview of clinical trials JO - World J Clin Oncol VL - 7 UR - https://doi.org/10.5306/wjco.v7.i4.331 DO - 10.5306/wjco.v7.i4.331 ID - Zafrakas2016 ER - TY - JOUR AU - Flanagan, J. M. PY - 2009 DA - 2009// TI - Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets JO - Mol Cancer Ther VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-08-0636 DO - 10.1158/1535-7163.MCT-08-0636 ID - Flanagan2009 ER - TY - JOUR AU - Shen, C. PY - 2017 DA - 2017// TI - Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway JO - Oncotarget VL - 8 ID - Shen2017 ER - TY - JOUR AU - Sharif, T. PY - 2016 DA - 2016// TI - The NAD+ salvage pathway modulates cancer cell viability via p73 JO - Cell Death Differ VL - 23 UR - https://doi.org/10.1038/cdd.2015.134 DO - 10.1038/cdd.2015.134 ID - Sharif2016 ER - TY - JOUR AU - Lanning, N. J. PY - 2017 DA - 2017// TI - Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities JO - Cancer Metab VL - 5 UR - https://doi.org/10.1186/s40170-017-0168-x DO - 10.1186/s40170-017-0168-x ID - Lanning2017 ER -